-+ 0.00%
-+ 0.00%
-+ 0.00%

Arcutis Biotherapeutics Q1 EPS $(0.20) Beats $(0.21) Estimate, Sales $65.85M Beat $62.25M Estimate

Benzinga·05/06/2025 20:03:43
Listen to the news
Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.21) by 4.76 percent. This is a 37.5 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $65.85 million which beat the analyst consensus estimate of $62.25 million by 5.78 percent. This is a 32.84 percent increase over sales of $49.57 million the same period last year.